JP5900044B2 - 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム - Google Patents

糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム Download PDF

Info

Publication number
JP5900044B2
JP5900044B2 JP2012054382A JP2012054382A JP5900044B2 JP 5900044 B2 JP5900044 B2 JP 5900044B2 JP 2012054382 A JP2012054382 A JP 2012054382A JP 2012054382 A JP2012054382 A JP 2012054382A JP 5900044 B2 JP5900044 B2 JP 5900044B2
Authority
JP
Japan
Prior art keywords
blood glucose
glucose level
meal
average
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012054382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013188240A (ja
JP2013188240A5 (enExample
Inventor
時田　宗雄
宗雄 時田
中嶋　聡
聡 中嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omron Healthcare Co Ltd
Original Assignee
Omron Healthcare Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omron Healthcare Co Ltd filed Critical Omron Healthcare Co Ltd
Priority to JP2012054382A priority Critical patent/JP5900044B2/ja
Priority to PCT/JP2012/079284 priority patent/WO2013136585A1/ja
Priority to DE112012006019.9T priority patent/DE112012006019T5/de
Priority to US14/377,737 priority patent/US9131903B2/en
Priority to CN201280071342.1A priority patent/CN104168829B/zh
Publication of JP2013188240A publication Critical patent/JP2013188240A/ja
Publication of JP2013188240A5 publication Critical patent/JP2013188240A5/ja
Application granted granted Critical
Publication of JP5900044B2 publication Critical patent/JP5900044B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7278—Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/486—Biofeedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Signal Processing (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Primary Health Care (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Epidemiology (AREA)
JP2012054382A 2012-03-12 2012-03-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム Active JP5900044B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2012054382A JP5900044B2 (ja) 2012-03-12 2012-03-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム
PCT/JP2012/079284 WO2013136585A1 (ja) 2012-03-12 2012-11-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム
DE112012006019.9T DE112012006019T5 (de) 2012-03-12 2012-11-12 Unterstützungsvorrichtung zur Diabetesbehandlung, Unterstützungsverfahren zur Diabetesbehandlung, Unterstützungsprogramm zur Diabetesbehandlung
US14/377,737 US9131903B2 (en) 2012-03-12 2012-11-12 Diabetes treatment support apparatus, diabetes treatment support method, diabetes treatment support program
CN201280071342.1A CN104168829B (zh) 2012-03-12 2012-11-12 糖尿病治疗支援装置、HbA1c推断值计算方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012054382A JP5900044B2 (ja) 2012-03-12 2012-03-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム

Publications (3)

Publication Number Publication Date
JP2013188240A JP2013188240A (ja) 2013-09-26
JP2013188240A5 JP2013188240A5 (enExample) 2015-04-23
JP5900044B2 true JP5900044B2 (ja) 2016-04-06

Family

ID=49160538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012054382A Active JP5900044B2 (ja) 2012-03-12 2012-03-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム

Country Status (5)

Country Link
US (1) US9131903B2 (enExample)
JP (1) JP5900044B2 (enExample)
CN (1) CN104168829B (enExample)
DE (1) DE112012006019T5 (enExample)
WO (1) WO2013136585A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102393711B1 (ko) 2013-10-17 2022-05-04 더 제너럴 하스피탈 코포레이션 자가면역 질환의 치료에 반응하는 대상체의 식별 방법 및 그의 치료를 위한 조성물
WO2016103390A1 (ja) * 2014-12-25 2016-06-30 株式会社日立製作所 インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法
KR101807854B1 (ko) * 2016-01-29 2017-12-12 주식회사 아이센스 임신성 당뇨병 환자를 위한 식사 시간 정보의 제공 방법
US11039986B2 (en) 2016-02-25 2021-06-22 Samsung Electronics Co., Ltd. Chronotherapeutic dosing of medication and medication regimen adherence
WO2017187212A1 (en) * 2016-04-28 2017-11-02 77 Elektronika Müszeripari Kft. Data processing method for blood glucose measuring, blood glucose meter, blood glucose measurement system, and computer program and data carrier therefor
KR20190006955A (ko) * 2016-05-13 2019-01-21 에이껜 가가꾸 가부시끼가이샤 측정 대상 물질의 비교 대상 물질에 대한 비율을 구하는 방법, 프로그램, 기억 매체 및 장치
US11464447B2 (en) 2016-06-30 2022-10-11 Novo Nordisk A/S Regimen adherence measure for insulin treatment based on glucose measurements and insulin pen data
CN108283486B (zh) * 2017-01-09 2021-04-09 腾讯科技（深圳）有限公司 测量数据的处理方法及装置
JP7149053B2 (ja) * 2017-04-25 2022-10-06 株式会社田中金属製作所 糖尿病予防又は改善用液状物
EP3917378B8 (en) * 2019-01-28 2025-04-23 MediBeacon Inc. Systems and methods for home transdermal gfr monitoring
CA3157672A1 (en) * 2019-11-25 2021-06-03 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
CN113128301A (zh) * 2019-12-31 2021-07-16 苏州三六零智能安全科技有限公司 视频鉴黄方法、系统、存储介质及其计算机设备
WO2025064603A1 (en) * 2023-09-21 2025-03-27 Abbott Diabetes Care Inc. Methods, devices, and systems for adjusting laboratory hba1c values

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001245900A (ja) 2000-03-02 2001-09-11 Arkray Inc グラフおよびグラフの表示方法並びにグラフ表示装置
JP4273036B2 (ja) * 2004-05-12 2009-06-03 中 奥村 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
JPWO2006009199A1 (ja) 2004-07-21 2008-05-01 松下電器産業株式会社 血糖値管理システム
US20070016449A1 (en) * 2005-06-29 2007-01-18 Gary Cohen Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
JP2008213098A (ja) * 2007-03-06 2008-09-18 Mitsubishi Heavy Ind Ltd 割り出しテーブル
US20080235053A1 (en) * 2007-03-20 2008-09-25 Pinaki Ray Communication medium for diabetes management
JP4889116B2 (ja) 2007-03-20 2012-03-07 旭化成ファーマ株式会社 肝疾患における正確な血糖コントロール状態および肝機能を算出する方法
JP5429586B2 (ja) * 2007-03-30 2014-02-26 株式会社タニタ 血糖状態推定方法及び装置
SG193205A1 (en) * 2008-08-15 2013-09-30 Lifescan Scotland Ltd Analyte testing method and system
US20100330598A1 (en) * 2009-06-26 2010-12-30 Roche Diagnostics Operations, Inc. METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR PROVIDING BOTH AN ESTIMATED TRUE MEAN BLOOD GLUCOSE VALUE AND ESTIMATED GLYCATED HEMOGLOBIN (HbA1C) VALUE FROM STRUCTURED SPOT MEASUREMENTS OF BLOOD GLUCOSE
JP2012024439A (ja) * 2010-07-27 2012-02-09 Seiko Epson Corp 血糖値予測システム

Also Published As

Publication number Publication date
US9131903B2 (en) 2015-09-15
CN104168829B (zh) 2016-12-07
JP2013188240A (ja) 2013-09-26
CN104168829A (zh) 2014-11-26
DE112012006019T5 (de) 2014-12-18
US20150038816A1 (en) 2015-02-05
WO2013136585A9 (ja) 2014-07-31
WO2013136585A1 (ja) 2013-09-19

Similar Documents

Publication Publication Date Title
JP5900044B2 (ja) 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム
JP5528701B2 (ja) 多レベルユーザーインターフェイスを有する計測器
JP5435945B2 (ja) 食後検査時間アラームを有する計測器
TWI504895B (zh) 操作分析物測量裝置的方法
DK2972378T3 (en) SYSTEM AND PROCEDURE TO ANALYZE BLOOD SUGAR DATA AND TO QUANTIFY SUCCESS OR FAILURE OF INSULIN THERAPY
JP6764784B2 (ja) 健康管理を支援するデータ管理ユニット
JP2015530889A (ja) 糖尿病患者のための高血糖又は低血糖を示す方法及びシステム
JP5697173B2 (ja) 血糖状態推定方法及び装置
CN103260514A (zh) 从连续葡萄糖监测器接收数据的手持糖尿病管理设备的校准
KR20140147849A (ko) 이전의 생리적 측정치의 분석에 기초한 사용자에 대한 긍정적 강화 메시지
Lurbe et al. Assessing ambulatory blood pressure in renal diseases: facts and concerns
JP6721408B2 (ja) 判定装置
Malbora et al. Ambulatory blood pressure monitoring of healthy schoolchildren with a family history of hypertension
Wilson et al. Assessing glycaemic control: self-monitoring of blood glucose
HK1223154B (en) System and methods for analyzing blood glucose data and quantifying the success for failure of insulin therapy
HK1197451B (en) Meter having multi-level user interface
HK1120626A (en) Meter having post-meal test-time alarm
HK1188311B (en) Updatability of structured blood glucose tests on handheld diabetes management devices
HK1188311A (en) Updatability of structured blood glucose tests on handheld diabetes management devices

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150218

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150309

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160209

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160222

R150 Certificate of patent or registration of utility model

Ref document number: 5900044

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150